Moorman AV, Harrison CJ, Buck GA et al : Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL) : analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109 (8) : 3189-3197, 2007.
Lee S, Kim YJ, MM CK et al : The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 105 (9) : 3449-3457, 2005.
Thomas DA, Faderl S, Cortes J et al : Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 103 (12) : 4396-4407, 2004.
Wassmann B, Pfeifer H, Goekbuget N et al : Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL). Blood 108 (5) : 1469-1477, 2006.